HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone.

AbstractBACKGROUND:
Suppression of spermatogenesis to azoospermia is required for effective hormonal male contraception, but the degree of suppression varies between ethnic groups. We here report the first study of hormonal suppression of spermatogenesis in two African centres using a regimen of oral progestogen with depot testosterone. METHODS A total of 31 healthy men (21 black) were recruited in Cape Town and 21 men in Sagamu, Nigeria. Subjects were randomized to take either 150 or 300 micro g desogestrel daily p.o. with testosterone pellets. In Cape Town, desogestrel was administered for 24 weeks with 400 mg testosterone re-administered 12 weekly. In Sagamu, desogestrel was administered for 52 weeks with 200 mg testosterone (later increased to 400 mg) re-administered 12-weekly.
RESULTS:
In Cape Town, 22 men completed at least 20 weeks treatment. Azoospermia was achieved in 8/10 and 8/12 men in the 150 micro g and 300 micro g desogestrel groups. Four men in Sagamu withdrew. Azoospermia was achieved in all 17 men in the two groups. There were no significant changes in lipoprotein or haemoglobin concentrations in any group.
CONCLUSION:
These data demonstrate that the combination of oral desogestrel with depot testosterone is an effective regimen for suppression of spermatogenesis in African as in Caucasian and Chinese men, with azoospermia achieved in a total of 83/98 (85%) men.
AuthorsR A Anderson, Z M Van Der Spuy, O A Dada, S K Tregoning, P M Zinn, O A Adeniji, T A Fakoya, K B Smith, D T Baird
JournalHuman reproduction (Oxford, England) (Hum Reprod) Vol. 17 Issue 11 Pg. 2869-77 (Nov 2002) ISSN: 0268-1161 [Print] England
PMID12407041 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Contraceptive Agents, Male
  • Contraceptives, Oral, Synthetic
  • Delayed-Action Preparations
  • Gonadal Steroid Hormones
  • Gonadotropins, Pituitary
  • Testosterone
  • Desogestrel
Topics
  • Administration, Oral
  • Adult
  • Africa (ethnology)
  • Black People
  • Cohort Studies
  • Contraceptive Agents, Male (administration & dosage, adverse effects)
  • Contraceptives, Oral, Synthetic (administration & dosage, adverse effects)
  • Delayed-Action Preparations
  • Desogestrel (administration & dosage, adverse effects)
  • Gonadal Steroid Hormones (administration & dosage, blood)
  • Gonadotropins, Pituitary (blood)
  • Humans
  • Male
  • Sexual Behavior (drug effects)
  • Sperm Count
  • Spermatogenesis (drug effects)
  • Testosterone (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: